Q1 up marginally. (the 18 sold in 4Q can be counted on for Q2 going forward due to known lagtime). Despite the miss on RIO sale, guidance yesterday remained unchanged at 11k to 13k procedures even after management said they would err on the side of caution in their estimates. That's a good sign.
Procedure guidance remained the same. 11,000-13,000 this year. A near double from last year on the high end. The growth is stellar. And my favorite part about MAKO (and what many newbies don't realize) is that MAKO gets $5,000+ for EACH procedure performed. Do the math: